PAPARO, LORELLA
 Distribuzione geografica
Continente #
NA - Nord America 922
EU - Europa 644
AS - Asia 352
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1929
Nazione #
US - Stati Uniti d'America 902
IT - Italia 384
CN - Cina 167
VN - Vietnam 144
FR - Francia 64
UA - Ucraina 49
IE - Irlanda 37
DE - Germania 34
GB - Regno Unito 31
CA - Canada 20
IN - India 20
FI - Finlandia 13
IL - Israele 10
MT - Malta 10
SE - Svezia 6
TR - Turchia 6
NL - Olanda 4
PE - Perù 4
BG - Bulgaria 3
CH - Svizzera 3
BR - Brasile 2
EG - Egitto 2
EU - Europa 2
PK - Pakistan 2
RS - Serbia 2
AU - Australia 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
IR - Iran 1
MK - Macedonia 1
PL - Polonia 1
RO - Romania 1
TH - Thailandia 1
Totale 1929
Città #
Chandler 379
Dong Ket 144
Napoli 85
Beijing 58
Millbury 56
Des Moines 55
Nanjing 47
Lawrence 42
Boston 26
Princeton 25
Menlo Park 16
Naples 15
Dearborn 14
Ottawa 14
Redwood City 14
Nanchang 13
Hebei 12
Wilmington 12
Melita 10
San Giorgio a Cremano 9
Tianjin 9
Shenyang 8
Ashburn 7
Changsha 7
Jerusalem 6
Milan 6
Cernobbio 5
Fairfield 5
Guangzhou 5
Bologna 4
Caserta 4
Houston 4
Lima 4
Nocera Inferiore 4
Palermo 4
Paris 4
Rome 4
Seregno 4
Torino 4
Bari 3
Bournemouth 3
Cambridge 3
Cava 3
Dallas 3
Istanbul 3
Milwaukee 3
Piovene Rocchette 3
Pistoia 3
San Gennaro Vesuviano 3
San Giorgio A Cremano 3
Sofia 3
Toronto 3
Woodbridge 3
Acerra 2
Adana 2
Cairo 2
Cava De' Tirreni 2
Celico 2
Fremont 2
Giugliano In Campania 2
Jacksonville 2
Jesi 2
Jiaxing 2
Leawood 2
Louisville 2
Lucca 2
Marcianise 2
Meudon 2
Nagold 2
Nürnberg 2
Piacenza 2
Pomigliano D'arco 2
Sarno 2
Shanghai 2
Adelaide 1
Ancona 1
Andover 1
Ann Arbor 1
Arienzo 1
Bacoli 1
Bangalore 1
Basel 1
Battipaglia 1
Blackburn 1
Castrovillari 1
Centro 1
Chicago 1
Doruk 1
Eboli 1
Ercolano 1
Evesham 1
Falls Church 1
Ferrandina 1
Freiburg im Breisgau 1
Garges-lès-Gonesse 1
Gdansk 1
Grumo Nevano 1
Gurgaon 1
Hangzhou 1
Karlsruhe 1
Totale 1254
Nome #
Meccanismi epigenetici nella patogenesi dell'allergia al latte vaccino 86
Corrigendum: Gut Microbiota Features in Young Children With Autism Spectrum Disorders 69
Gut Microbiota Features in Young Children with Autism Spectrum Disorders. 68
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 61
Food allergies: Novel mechanisms and therapeutic perspectives 58
Gut microbiota as target for innovative strategies against food allergy. 58
Cow's milk and fermented rice with L. paracasei CBA L74 prevent infectious diseases in children: a randomized controlled trial 54
Direct effects of fermented cow's milk product with Lactobacillus paracasei CBA L74 on human enterocytes 50
Differences in DNA methylation profile of Th1 and Th2 cytokine genes are associated with tolerance acquisition in children with IgE-mediated cow's milk allergy 49
Specific signatures of the gut microbiota and increased levels of butyrate in children treated with fermented cow's milk containing heat-killed Lactobacillus paracasei CBA L74 49
Evaluation of Lactobacillus rhamnosus GG Heat-Stability During Infant Formula Preparation 48
Altered miR-193a-5p expression in children with cow's milk allergy 48
Epigenetic features of FoxP3 in children with cow’s milk allergy 44
Extensively hydrolyzed casein formula alone or with L. rhamnosus GG reduces β-lactoglobulin sensitization in mice 43
Short-term effects of dietary bovine milk on fatty acid composition of human milk: a preliminary multi-analytical study 42
Specific gut microbiome signatures and the associated pro-inflamatory functions are linked to pediatric allergy and acquisition of immune tolerance 42
Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow’s milk allergy 41
Bifidobacteriumanimalissubsp.lactis BB-12 is effective in the treatment of infant colic: result of a randomized controlled trial 40
Phenylalanine Butyramide Is a New Cosmetic Ingredient with Soothing and Anti-Reddening Potential 40
Gut Microbiota as a Target for Preventive and Therapeutic Intervention against Food Allergy 39
Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants 38
Healthy infants harbor intestinal bacteria that protect against food allergy. 38
Randomized controlled trial on the influence of dietary intervention on epigenetic mechanisms in children with cow's milk allergy: the EPICMA study 37
A NEW HUMAN DYSKERIN ISOFORM WITH CYTOPLASMIC LOCALIZATION 36
How junk food can contribute to the food allergy epidemic: the potential role of advanced glycation endproducts. 36
Tolerogenic effect elicited by protein fraction derived from different hypoallergic formulas in PBMCs from children with cow milk allergy 35
MODULATION OF EPIGENETIC MECHANISMS BY DIETARY INTERVENTION IN CHILDREN WITH COW MILK ALLERGY 34
Butyrate as bioactive human milk protective component against food allergy 34
The effect of different formulas in children with cow ' s milk allergy on the occurrence of other allergic manifestations and the time of immune tolerance acquisition: The atopic march II study 34
Commentary: Raw Cow Milk Consumption and Atopic March 34
Preventive Effect of Cow's Milk Fermented with Lactobacillus paracasei CBA L74 on Common Infectious Diseases in Children: A Multicenter Randomized Controlled Trial 33
Hepatic Mitochondrial Dysfunction and Immune Response in a Murine Model of Peanut Allergy. 33
Antibody-independent identification of bovine milk-derived peptides in breast-milk 32
The Potential Immunonutritional Role of Parmigiano Reggiano Cheese in Children with Food Allergy 32
A NEW BUTYRATE-RELEASER COMPOUND FOR THE TREATMENT OF COW'S MILK ALLERGY. 32
Excretion of dietary cow’s milk derived peptides into breast milk 31
Butyrate against paediatric obesity: results of the BAPO trial 30
The Influence of Fiber on Gut Microbiota: Butyrate as Molecular Player Involved in the Beneficial Interplay Between Dietary Fiber and Cardiovascular Health 29
Targeting the gut microbiota to combat allergies 29
The potential role of advanced glycation end products in food allergy pathogenesis 29
IMMUNOREGULATORY EFFECT OF PARMIGIANO REGGIANO CHEESE IN CHILDREN WITH COW'S MILK ALLERGY. 28
The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic: A randomised, double blind, placebo-controlled trial 28
NGS Gene Panel Analysis Revealed Novel Mutations in Patients with Rare Congenital Diarrheal Disorders 28
DIETARY TREATMENT WITCH EXTENSIVELY HYDROLYZED CASEIN FORMULA WITH THE PROBIOTIC L.RHAMNOSUS GG PREVENTS THE OCCURRENCE OF FUNCTIONAL GASTROINTESTINAL DISORDERS IN CHILDREN WITH COW'S MILK ALLERGY 27
Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract 27
Analysis of immune, microbiota and metabolome maturation in infants in a clinical trial of Lactobacillus paracasei CBA L74-fermented formula 25
Beta catenin and cytokine pathway dysregulation in patients with manifestations of the “PTENhamartoma tumor syndrome” 24
MODULATION OF EPIGENETIC MECHANISMS BY DIETRAY INTERVENTION IN CHILDREN WITH COW MILK ALLERGY. 24
Potential Beneficial Effects Of Butyrate Against Food Allergy 22
The Impact of Formula Choice for the Management of Pediatric Cow's Milk Allergy on the Occurrence of other Allergic Manifestations: The Atopic March Cohort Study 22
Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection 21
N-P-004 Preventive effect of human milk against food allergy: new insights into butyrate activities. 20
Epigenetic Regulation of Early Nutrition on Immune System 20
N-P-015 Mirnome analysis highlights a specific cow’s milk allergy-related epigenic signature. 20
Publisher Correction: Randomized controlled trial on the influence of dietary intervention on epigenetic mechanisms in children with cow's milk allergy: the EPICMA study 20
Evaluation of l. rhamnosusgg heat- stability during formula preparation according to fao/who recommendation. 19
Immunonutrition for Pediatric Patients With Cow's Milk Allergy: How Early Interventions Could Impact Long-Term Outcomes 19
Protective effects of the postbiotic deriving from cow's milk fermentation with L. paracasei CBA L74 against Rotavirus infection in human enterocytes 19
Targeting Food Allergy with Probiotics. 15
Dietary Prevention of Atopic March in Pediatric Subjects With Cow's Milk Allergy 15
Preventive effect of human milk against food allergy: new insights into butyrate activities 14
Breast milk butyrate as protective factor against food allergy 14
Food allergy is associated with altered epithelial gene expression driven by early life dysbiosis 13
Protective effects elicited by cow milk fermented with L. Paracasei CBAL74 against SARS-CoV-2 infection in human enterocytes 13
N-P-016 Tolerogenic mechanisms elicited by extensively hydrolysed casein formula with L. rhamnosus GG. 12
Tolerogenic Effect Elicited by Protein Fraction Derived From Different Formulas for Dietary Treatment of Cow’s Milk Allergy in Human Cells 12
The gut microbiome-derived metabolite butyrate is able to exert a protective action against the deleterious effects of ultra-processed foods in facilitating food allergy 11
The evaluation of tolerance rate and the immune tolerance acquisition in children with cow's milk allergy switching from amino acid-based formula to extensively hydrolyzed casein formula: the SDACMA project. 9
Tolerogenic mechanisms elicited by extensively hydrolysed casein formula with L. rhamnosus GG 9
Effects of butyrate against pediatric obesity: the Bapo randomized-controlled trial. 7
Cytokine network involved in non-IgE- mediated gastrointestinal food allergy: results from NIGEFA project. 6
Potential role of omega-3 polyunsaturated fatty acids in pediatric food allergy 5
Body growth assessment in children with IgE-mediated cow's milk protein allergy fed with a new amino acid-based formula 3
Effects of the Mediterranean Diet during pregnancy on the onset of allergy in at risk children: A study protocol of a multi-center, randomized- controlled, parallel groups, prospective trial (the PREMEDI study) 3
Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial 2
Totale 2271
Categoria #
all - tutte 3786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201831 0000 00 47 6608
2018/2019254 143819 230 7161 2031310
2019/2020409 160152712 1330 1915 15433624
2020/2021352 17122412 833 1718 261815152
2021/2022591 121635 308 1714 3662199171
2022/2023503 76953793 9998 50 0000
Totale 2271